High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific

Arti M Raghubar1,2,3,4,5,6, Nicholas A Matigian7, Joanna Crawford5

  • 1Kidney Health Service, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.

NPJ Precision Oncology
|September 11, 2023
PubMed

Insights

High-risk clear cell renal cell carcinoma (ccRCC) tumors have exhausted immune cells unfavorable for immunotherapy. Spatial transcriptomics reveals these tumors are immunogenic but not responsive to immune checkpoint inhibitors (ICIs).

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Perioperative immune checkpoint inhibitor (ICI) trials for high-risk clear cell renal cell carcinoma (ccRCC) have yielded inconsistent patient outcomes.
  • This suggests that the tumor microenvironment (TME) immune cell composition and spatial organization may be unfavorable for ICI therapy.

Purpose of the Study:

  • To define the immunophenotypes within the ccRCC TME using spatial transcriptomics.
  • To identify predictive immune cell signatures associated with treatment response in ccRCC.

Main Methods:

  • Spatial transcriptomics sequencing (ST-seq) was performed on fresh para-tumour (pTME), low-grade (LG), and high-grade (HG) ccRCC tissue samples.
  • Immune cell types and states (exhausted/pro-tumour vs. non-exhausted/anti-tumour) were identified using reference single-cell RNA and T-cell receptor sequencing datasets.

Main Results:

  • High-grade ccRCC TMEs exhibit abundant exhausted/pro-tumour immune cells without increased expression of common checkpoints (PD-1, PD-L1, CTLA4) or angiogenic genes.
  • Distinct HG TME features include pro-tumour monocytes expressing HAVCR2 and LAG3, exhausted CD8+ T cells with stem-like progenitor gene expression, and pro-tumour macrophages/monocytes expressing TREM2.

Conclusions:

  • This study provides the largest ST-seq dataset for human ccRCC, revealing exhausted/pro-tumour immunophenotypes in high-risk ccRCC TMEs.
  • Despite being immunogenic, HG ccRCC TMEs are characterized by immune cell states that are not favorable for immune checkpoint inhibitor treatment.

Related Concept Videos